Biovica attends capital market day

Biovica will give a company presentation at the annual Unicorn Summit Capital Market Day. The summit gathers some of the most interesting and innovative companies in Sweden and is arranged annually by Vator Securities AB. In addition to company presentations, the 150 attendees and participants have the opportunity to network with industry peers as well [...]

2017-01-03T10:44:19+00:00 September 9th, 2016 09:00|News|

Expanded US patent approval for DiviTum™

Biovica has received expanded patent approval for the DiviTum™ kit-technology by the United States Patent and Trademark office. The patent protection for DiviTum™ now includes both the method and kit. DiviTum™ has patent protection in the US & Canada and across Europe, in total 49 countries. Biovica has developed DiviTum™, a non-invasive blood test, for [...]

2017-01-03T10:41:14+00:00 August 31st, 2016 09:00|Press Release|

Biovica interviewed in Vatorpodden

Listen to Anders Rylander, CEO of Biovica and Mattias Bergqvist VP Sales & Marketing being interviewed in the latest edition of Vatorpodden. Anders and Mattias discuss challenges of cancer diagnostics and how Biovica assists with its products and technology. The interview is available in Swedish (only)

2017-01-03T10:45:07+00:00 June 21st, 2016 13:36|News|

Biovica successfully raise sek 30 million in an oversubscribed issue of new shares

Biovica has successfully managed to ensure funds to deliver on the company’s business plan. Together with its financial advisor, Vator Securities, SEK 30 million have been raised in an oversubscribed issue of new shares. Biovica has developed a blood test for the rapid and reliable evaluation of therapy efficacy in patients with advanced cancer. The [...]

2017-01-03T10:45:27+00:00 June 20th, 2016 11:45|Press Release|

Biovica participates at ASCO, June 3-7, Chicago

Biovica will attend the ASCO Annual Meeting, an event that brings together 30 000 oncology professionals from around the world. Biovica aims to expand the collaboration and research network and to share the latest insights from on going clinical trials. “At ASCO we look forward to meet our academic partners and to expand [...]

2017-01-03T10:45:48+00:00 May 31st, 2016 08:30|News|

Biovica acquires cSens – creating opportunities for solving cancer diagnostic challenges

Biovica has acquired cSens AB, a company that has developed a PCR-based platform for the analysis of serum thymidine kinase (TK) enzyme activity, which correspond to tumor proliferation and cancer aggressiveness. The cSens technology complements Biovica’s current TK assay DiviTum ™, which is currently included in clinical studies with leading cancer institutes throughout the world. [...]

2017-01-03T10:46:09+00:00 May 17th, 2016 08:30|Press Release|

Maria Holmlund elected new member of Biovica board of directors

Maria Holmlund was elected as a new member of the Biovica board of directors at an extra shareholders meeting held on March 30, 2016. Maria has 30 years of experience in the life science and diagnostic industry and she has previously held senior management positions as CEO, business area manager and marketing manager at [...]

2017-01-03T10:47:40+00:00 May 4th, 2016 14:00|Press Release|

Poster accepted for presentation at the 2016 aacr annual meeting in New Orleans

The American Association for Cancer Research (AACR) annual meeting is one of the largest gatherings of cancer researchers and oncologists in the world. The meeting is held 16-20 April in New Orleans. Biovica is attending the meeting to present a poster with new DiviTum™ results to demonstrate its use as a marker of efficacy for cell [...]

2017-01-03T10:48:13+00:00 April 1st, 2016 09:00|News|

Biovica participates at the bio-europe conference, 4-6 april in Stockholm

Biovica will attend one of the largest partnering conferences serving the global biotechnology and pharmaceutical industry. The conference attracts leading dealmakers from biotech, pharma and finance along with the most exciting emerging companies. This years spring meeting is arranged in Stockholm at Kistamässan. “With DiviTum™ we provide researchers and pharmaceutical companies with a tool for [...]

2017-01-03T10:48:31+00:00 March 18th, 2016 09:00|News|